Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01318642
Recruitment Status : Terminated (NCT01318642: Planned independent DMC Interim review: ended for futility w/no safety concerns)
First Posted : March 18, 2011
Last Update Posted : August 8, 2014
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2012
  Actual Study Completion Date : December 2012
  Certification/Extension First Submitted : May 29, 2014